Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

about

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

Item

http://www.wikidata.org/entity/Q50432748

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@en

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@nl

type

Item

label

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@en

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@nl

prefLabel

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@en

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@nl

P1476

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

@en

P2093

Ajit Sood

http://www.w3.org/2001/XMLSchema#string

Savita Jain

http://www.w3.org/2001/XMLSchema#string

Vandana Midha

http://www.w3.org/2001/XMLSchema#string

P2860

Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy

[A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].

Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.

A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.

Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea.

Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.

The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B.

P2888

s12664-011-0126-4

P304

239-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12664-011-0126-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51706456

http://www.w3.org/2001/XMLSchema#string

P698

21986854

http://www.w3.org/2001/XMLSchema#string